Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$15.96M-0.7%$16.08M-8.8%$17.63M+17.5%$15.01M+14.2%$13.14M-3.5%
$6.22M+14.3%$5.44M-5.5%$5.76M+16.5%$4.94M+3.1%$4.79M+114%
$9.74M-8.4%$10.64M-10.4%$11.88M+17.9%$10.07M+20.6%$8.35M-26.7%
61%-5.1pp66.2%-1.2pp67.4%+0.3pp67.1%+3.5pp63.5%-20.0pp
$154K-46.3%$287K$0-100%$39K-82.1%
$10.11M+2.5%$9.86M-18.2%$12.05M+1.4%$11.88M+12.4%$10.57M+5.1%
$17.45M+5.6%$16.52M-13.8%$19.16M+7.1%$17.89M+8.6%$16.46M+44.6%
-$1.49M-237%-$443K+71.0%-$1.53M+46.8%-$2.88M+13.5%-$3.32M
-9.3%-6.6pp-2.8%+5.9pp-8.7%+10.5pp-19.2%+6.1pp-25.3%
$892K-4.4%$933K-0.4%$937K0.0%$937K+5.2%$891K+7.2%
-$738K+8.2%-$804K-2.3%-$786K+8.6%-$860K-14.8%-$749K-14.9%
-$2.23M-78.8%-$1.25M+46.1%-$2.32M+38.0%-$3.74M+8.3%-$4.07M
-$2.23M-78.8%-$1.25M+46.1%-$2.32M+39.0%-$3.8M+6.8%-$4.07M
-14%-6.2pp-7.8%+5.4pp-13.1%+12.2pp-25.3%+5.7pp-31%
-$0.08-100%-$0.04+55.6%-$0.09+43.8%-$0.16+11.1%-$0.18
-$366K-159%$622K+234%-$465K+74.3%-$1.81M+19.8%-$2.26M
-2.3%-6.2pp3.9%+6.5pp-2.6%+9.4pp-12.1%+5.1pp-17.2%
-$1.49M-237%-$443K+71.0%-$1.53M+46.8%-$2.88M+13.5%-$3.32M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Journey Medical Corporation's revenue?
Journey Medical Corporation (DERM) generated $64.7M in revenue over the trailing twelve months, up 15.0% year over year.
Is Journey Medical Corporation profitable?
Journey Medical Corporation is not currently profitable: it reported a net loss of $9.6M over the trailing twelve months, a -14.8% net margin.
What are Journey Medical Corporation's profit margins?
Gross margin is 65.4% and operating margin is -9.8%, with a -14.8% net margin.
What is Journey Medical Corporation's earnings per share?
Journey Medical Corporation's diluted EPS over the trailing twelve months is $-0.37.
Where does Journey Medical Corporation's income statement data come from?
Every line is extracted from Journey Medical Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.